Clinical Trial Update: Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Pola-RCHP-X to Pola-RCHP in previously untreated diffuse large B-cell lymphoma to assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Pola-RCHP
• Pola-RCHP-X

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: RECRUITING